Synthetic Psilocybin Shows Strong Results in Treatment-Resistant Depression Trials
Regulators are now mulling the results of the late-stage trial
Read the full articleYou might also wanna read
Final psychedelics guidance suggests FDA is 'receptive' to helping companies succeed
The agency’s finalized recommendations for clinical testing of psychedelic compounds for mental health could pave the way for companies like
Real-World Study Shows Psilocybin Improves Treatment-Resistant Depression Symptoms
One of the first real-world studies of psilocybin therapy suggests meaningful improvements in treatment-resistant depression outside the con
mdsc.pe·20d ago
The debate about whether the NHS should use magic mushrooms to treat depression
Many clinical trials to test the use of psychedelic medicines for conditions such as depression have been underway since 2022 - with surpris
Psychedelic Nation? Psilocybin Treatments Offer New Hope for People Prozac Hasn’t Helped
Psychedelic medications, backed by the White House, may alter the prognosis for people with treatment-resistant depression, but risks remain
Australia Refined its Psychedelic Therapy Framework — Here's What's Changed
Almost three years ago, Australia made history when the Therapeutic Goods Administration (TGA) approved access to MDMA for the treatment of
The future of US psychedelic medicine is carved out by the FDA
The US Food and Drug Administration (FDA) has issued its first comprehensive guidance on how psychedelic drugs should best be studied in cli
The future of US psychedelic medicine is carved out by the FDA
The US Food and Drug Administration (FDA) has issued its first comprehensive guidance on how psychedelic drugs should best be studied in cli
Comments
Sign in to join the conversation.
No comments yet. Be the first.